Finance & digital strategy

Choose pharma AI use cases by decision risk and measurable value

By NextEdge LabsUpdated 9 min read

For CIO CTO and business sponsors · Understand the problem

TL;DR — what you’ll learn

  • Start with a specific business decision or task before selecting an AI technique.
  • Compare process improvement, rules, integration and AI against the same operating problem.
  • Assess data readiness, failure consequences, human authority and lifecycle effort alongside potential value.
  • Select bounded pilots with baseline evidence, meaningful evaluation and explicit scale or stop conditions.

A portfolio of chatbot ideas is not yet a roadmap

Every department proposes an AI assistant. Procurement wants document extraction, engineering wants maintenance recommendations and quality wants faster batch review. The proposals use similar language, but their data, consequences and approval needs differ substantially.

Prioritising AI in the pharmaceutical industry should begin with the work and the decisions it supports. A useful roadmap explains why a particular intervention is appropriate, what evidence will establish value and who remains accountable when the output is uncertain or wrong.

NIST's AI Risk Management Framework is intended for voluntary use in managing AI risks. It provides useful technical context, but does not certify pharmaceutical compliance or replace the organisation's applicable quality requirements. NIST AI Risk Management Framework.

Describe each proposal as an operating problem

Require a short statement identifying the current task, user, input, output and next decision. “Use AI for quality” is too broad. “Help a reviewer locate the approved documents relevant to a defined change assessment” is concrete enough to examine.

Record the current pain with evidence: time spent, errors, delays, repeated clarification or incomplete handovers. Use a representative sample of actual work rather than a memorable difficult case alone. The baseline should include exception effort and review time.

Name a business owner who can change the process and a domain owner who can assess output quality. A proposal without an accountable operating owner may remain a demonstration even if the technology performs well.

Compare the available interventions

Consider whether the problem arises from unclear responsibility, poor source data, missing integration, repetitive rules or genuinely variable information. Different causes call for different interventions.

If two systems disagree because their identifiers are mapped incorrectly, improving the mapping may be more effective than adding a language model. If users cannot find the current SOP because versions are unmanaged, document control needs attention before generated answers can be trusted.

The integration exception guide addresses deterministic event failures. The SOP assistant guide addresses a bounded retrieval use. Comparing these approaches helps the portfolio choose the appropriate tool for the specific need.

Assess value with a credible denominator

Estimate the volume of eligible work and the current effort per item. Separate routine items from difficult exceptions. A pilot tested only on clean documents should not be assumed to cover all incoming material.

Describe the expected benefit as reduced handling, improved retrieval, fewer unresolved discrepancies or another observable outcome. Avoid claiming cash savings from hours alone. Capacity released has value, but a cash benefit requires a documented change in spending or another recognised financial consequence.

The automation business-case guide explains the financial bridge. Use its approach consistently across proposals so the portfolio does not favour whichever team uses the most optimistic terminology.

Examine data readiness before scoring sophistication

Identify the authoritative data, its permitted use, coverage, quality and accessibility. Check whether the relevant records contain the context needed for the intended output. A large document collection can still lack current versions or reliable identifiers.

Assess whether representative evaluation data is available with appropriate protection. The team needs examples of routine work, difficult cases and known failure modes. If reviewers cannot establish the correct or acceptable outcome, a performance score may be difficult to interpret.

Include integration dependencies and maintenance. A prototype using manually curated files may not represent the effort required to keep production data current. Record who will own that work and what happens when a source changes.

Worked example: compare three proposals

Consider an illustrative portfolio with three candidates: extracting fields from supplier documents, suggesting a maintenance triage category and supporting batch disposition. The proposals have different decision consequences even if all use language models.

For document intake, the proposed output is a draft set of fields linked to the source. A qualified user verifies consequential information before it enters the approved workflow. The pilot can measure extraction errors, review effort and missing-source handling with a bounded document set.

For maintenance triage, the output is a suggested routing category based on approved work-order information. Engineering must assess whether a wrong category could delay a critical response. The pilot needs an appropriate fallback and must not issue hazardous operating instructions or authorise equipment return to service.

For batch disposition, the consequence is materially different. A generated recommendation must not be treated as an autonomous release decision. The team may instead identify a narrower evidence-retrieval or reconciliation task that supports the authorised reviewer without transferring their decision authority.

On these stated assumptions, document intake may be the most practical first pilot if the data and reviewer capacity are ready. That is an illustrative prioritisation, not a universal ranking or a claim of proven savings.

Use a scorecard with explicit gates

A scorecard can organise discussion, but a weighted total should not conceal an unresolved critical condition. Use eligibility gates for matters such as a defined owner, permitted data use, an acceptable decision boundary and a feasible evaluation approach.

Then compare eligible proposals on the dimensions that matter to the business. Keep the supporting evidence next to each score so the ranking remains explainable.

Scroll horizontally to see all columns.

Use a scorecard with explicit gates
DimensionEvidence to request
Business valueBaseline volume, effort and consequence of the current problem
Data readinessAuthoritative sources, quality, permissions and update process
Decision consequenceWhat happens if the output is wrong, missing or late?
Review designWho checks the output and what evidence do they have?
Evaluation feasibilityRepresentative cases and defined acceptance criteria
Delivery effortIntegration, assurance, change and support dependencies
ReversibilityHow the organisation can stop or recover safely

For a simple illustrative scoring method, use one to five for value and readiness, but show decision risk separately rather than subtracting it into an opaque total. The exact method is a management choice; it should make trade-offs visible.

Define meaningful human review

“Human in the loop” is incomplete unless the reviewer has time, authority and evidence to challenge the output. Specify what they inspect, what decisions they can make and how uncertainty is escalated.

Test whether the proposed interface encourages over-reliance. A confident recommendation displayed above a hidden source may be difficult to challenge in practice. Show relevant evidence and uncertainty where the user makes the decision, with a workable route to the underlying record.

Measure reviewer corrections and the effort needed to reach an acceptable outcome. If the AI creates new checking work equal to the time it saves, the business case should reflect that result rather than counting only generation speed.

Build evaluation around consequences

Define failure categories relevant to the intended use: omitted information, unsupported additions, wrong source version, incorrect routing, restricted-data disclosure or inability to abstain. Aggregate accuracy may conceal the category that matters most.

Use a representative evaluation set that is separate from examples used to tune the system where feasible. Include difficult and negative cases, such as questions with no supported answer. Record the scope of the test so results are not presented as evidence for every future use.

NIST's Generative AI Profile cautions against broad capability conclusions from narrow assessments and discusses risks specific to generative systems. Apply those ideas through use-specific evaluation rather than a generic claim that the model is reliable. NIST Generative AI Profile.

Include quality, privacy and security early

Assess intended use with the relevant quality function and identify applicable assurance requirements. A low-cost prototype can still create a consequential operating reliance if users begin acting on its output. Define the pilot boundary and permissions clearly.

Map information sent to models, retrieval services, logs and support systems. Confirm the permitted handling with privacy, security and supplier owners. A model endpoint should not receive all available data simply because it can accept a large context.

Review prompt injection, unauthorised retrieval and connected tool actions where relevant. Restrict capabilities to the intended purpose and test the failure response. A retrieval assistant should not acquire permission to change quality records merely because the underlying platform supports tools.

Plan the lifecycle before approving the pilot

List the components that can change: model, prompts, retrieval index, document sources, mappings, permissions and user workflow. Assign ownership for assessing changes and repeating the relevant evaluation.

Estimate recurring costs for hosting or usage, support, review, source maintenance, monitoring and assurance. Include incident investigation and supplier changes. A prototype's low run cost may omit much of the actual operating effort.

Define continuity and exit. Users need an approved fallback when the service is unavailable or suspended. Retained records and decisions should remain accessible without depending indefinitely on the same model or supplier.

Set scale, revise and stop conditions

Agree the pilot's acceptance conditions before examining results. They should cover useful performance, unacceptable failure categories, reviewer effort, adoption and operating ownership. A compelling demonstration should not rewrite the criteria after the fact.

Use three possible outcomes. Scale when evidence supports the intended use and operating model; revise when specific fixable gaps remain; stop when value or controllability is insufficient. Stopping a weak pilot can be a good portfolio decision rather than a project failure.

Record what the pilot has not established. A successful document-extraction test does not demonstrate suitability for medical assessment or batch disposition. Expansion to a new task needs its own intended-use and evidence assessment.

Keep an unresolved-assumptions list with the decision record. Each assumption should have an owner and a proposed way to verify it, so the next funding discussion can distinguish new evidence from repeated optimism.

Build a roadmap from dependencies

Sequence source-data improvement, access control and integration work before the AI functions that depend on them. Shared foundations can benefit several departments, but each use case still needs its own acceptance evidence and accountable owner.

Limit simultaneous pilots to the organisation's capacity to review and operate them. Several unfinished experiments can consume specialist time without producing a supported service. A smaller portfolio with clear decisions is easier to maintain and evaluate.

NextEdge Labs can help turn candidate ideas into bounded workflow assessments, evaluation scenarios and integration plans. The useful deliverable is a decision-ready pilot scope with measurable outcomes and explicit authority, not a broad promise that AI will transform every function.

Summary and next actions

AI prioritisation works when the organisation compares specific tasks using evidence, consequence and operating effort. The best first pilot is one the team can evaluate, control and use to make a clear next decision.

  • Rewrite each candidate as a task with a user, source, output and accountable decision owner.
  • Compare process, rules, integration and AI options against the same baseline problem.
  • Apply eligibility gates and assess value, readiness, review effort and failure consequences.
  • Select bounded pilots with predefined evaluation, lifecycle ownership and scale, revise or stop conditions.

Recognise this problem in your operation?

Tell us where the records or handovers break down. We can discuss the process, data and software questions worth examining first.

START A CONVERSATION

Let’s talk about your next build.

Prepare your brief below, then review and send it in your email app to sales@nextlabsonline.com.

SELECTED INDUSTRYPharma & life sciences

Article: Choose pharma AI use cases by decision risk and measurable value

THE FIRST CONVERSATION

Your product idea, AI opportunity or automation challenge—and a useful first milestone.

All fields are required.

A few sentences about the problem, your users and timing are enough.

We’ll use your details to respond to your enquiry. Please don’t include patient records, passwords or confidential information. Privacy Policy · Website Terms.

About this guide

NextEdge Labs develops software, integrations and AI-assisted workflows. This guide presents practical workflow analysis with linked source references. Worked examples are illustrative, not client results.

Apply the sources within their stated market and scope, together with your approved procedures and the decisions of the responsible specialists.

Browse all Pharma & life sciences guides or explore our engineering capabilities.